LeukoTreat public conference – Berlin July 2, 2013



Written on Tuesday 25 June 2013

The LeukoTreat partners are organizing a public conference on therapeutic strategies for leukodystrophies, which will be held on July 2nd, 2013 at the Estrel Convention Center in Berlin in association with the XI European Meeting on cells" class="glossy" title="Cells of the nervous system that provide support and nutrition to the neurons." >Glial Cells (July 3-6).

 

 

 

 

 

DOWNLOAD the PROGRAM and CONFERENCE INFORMATION

FREE REGISTRATION

REGISTER NOW (mandatory)

 

ABOUT LEUKOTREAT
LeukoTreat is a European project funded by the European Commission under the 7th Framework Programme for Research and Development. It aims at developing therapeutic strategies for the largest number of leukodystrophy affected patients as well as the development of further applications to more common white matter disorders and neurodegenerative diseases.
Launched in 2010, LeukoTreat gathers 24 partners from 8 different countries. The project combines the expertise of recognized European research teams in the field of white matter diseases, high technology SMEs, experts in medical ethics and LD patients and families associations. For more information, please visit: www.leukotreat.eu

This conference has received funding from the European Union Seventh Framework Programme ([FP7/2007‐2013]) under grant agreement n°241622.

LeukoTreat public conference_slide